SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-254386
Filing Date
2012-05-31
Accepted
2012-05-31 06:05:08
Documents
10
Period of Report
2012-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d360463d8k.htm 8-K 37917
2 LETTER AGREEMENT d360463dex11.htm EX-1.1 90909
3 ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION d360463dex31.htm EX-3.1 79653
4 FORM OF SERIES 15-1 PREFERRED STOCK CERTIFICATE d360463dex41.htm EX-4.1 7542
5 FORM OF SERIES 15-2 PREFERRED STOCK CERTIFICATE d360463dex42.htm EX-4.2 7707
6 FORM OF WARRANT TO PURCHASE COMMON STOCK. d360463dex43.htm EX-4.3 118088
7 OPINION OF KARR TUTTLE CAMPBELL. d360463dex51.htm EX-5.1 13505
8 FORM OF SECURITIES PURCHASE AGREEMENT. d360463dex101.htm EX-10.1 167629
9 PRESS RELEASE d360463dex991.htm EX-99.1 21150
10 GRAPHIC g360463img001.jpg GRAPHIC 4250
  Complete submission text file 0001193125-12-254386.txt   551432
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 12879238
SIC: 2834 Pharmaceutical Preparations